Pipecuronium bromide
![Word Embedding Mining for SARS-Cov-2 and COVID-19 Drug Repurposing [Version 1; Peer Review: 2 Approved with Reservations]](http://data.docslib.org/img/264x/207164329a6811dfd5b149774444627c.webp)
Top View
- Chapter 13 – Pharmacology of Muscle Relaxants and Their Antagonists Mohamed Naguib, Cynthia A
- Pancuronium Bromide(BAN, USAN, Rinn)
- WO 2008/134525 Al
- (12) United States Patent (10) Patent No.: US 7,199,151 B2 Shashoua Et Al
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- Federal Register/Vol. 76, No. 110/Wednesday, June 8, 2011
- Marrakesh Agreement Establishing the World Trade Organization
- Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Atc Index 2010
- Neuromuscular Blockade in the Elderly Patient
- Neuromuscular Blockade in the Elderly Patient
- Pharmaabkommen A1 E
- Customs Tariff - Schedule Xxi - 1
- Neuromuscular and Cardiovascular Effects of Pipecuronium Dose-Response and in All the Clinical the 2 X ED95 Doses of Pipecuronium and Vecuronium Studies
- Nicotinic Acetylcholine Receptors
- Harmonized Tariff Schedule of the United States (2006) (Rev